Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Affimed (DE:A28)
STUTTGART:A28
Affimed (A28) Stock Forecast & Price Target
0 Followers
See the Price Targets and Ratings of:
A28 Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
A28 Stock 12 Month Forecast
Average Price Target
€4.57
▼(-1.98% Downside)
| Highest Price Target€4.57 | Average Price Target€4.57 | Lowest Price Target€4.57 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
H.C. Wainwright
€4.57
Buy
-1.98%
Downside
Reiterated
12/14/23
Buy Rating Reaffirmed for Affimed as Promising Clinical Trials Propel Optimism
Leerink Partners
€4.57
Buy
-1.98%
Downside
Reiterated
12/12/23
We were surprised and encouraged by the early positive signal with AFM24 (EGFR innate cell engager) + atezolizumab (atezo, anti-PDL1) in PD-1 relapsed / refractory, EGFRwt non-small cell lung cancer (NSCLC) and believe the stock may more positively reflect these data over time. In this very difficult setting where we expect little to no activity with atezo alone, the combination drove four responses (two confirmed), including a confirmed complete response (CR). Such activity is stand-out among immuno-oncology (IO)-only regimens in the setting. If confirmed in more patients in 2024, this signal warrants investment either in the r/r setting (if durability is also promising) or in combination with a cytotoxic (potentially an antibody drug conjugate [ADC]) and/or the r/r or 1L setting.
Wells Fargo
€2.74
Buy
-41.19%
Downside
Assigned
11/14/23
Analysts Are Bullish on Top Healthcare Stocks: Syros Pharmaceuticals (SYRS), Affimed (AFMD)
Truist Financial
―
Buy
―
Reiterated
11/14/23
Truist Financial Reaffirms Their Buy Rating on Affimed (AFMD)
Wolfe Research
€5.48
Buy
17.62%
Upside
Reiterated
08/10/23
Berenberg Bank Reaffirms Their Buy Rating on Affimed (AFMD)
Berenberg Bank
€5.48
Buy
17.62%
Upside
Reiterated
05/24/23
Berenberg Bank Reaffirms Their Buy Rating on Affimed (AFMD)
Stifel Nicolaus
€0.91
Hold
-80.40%
Downside
Reiterated
03/24/23
Affimed price target lowered to $1 from $2 at StifelAffimed price target lowered to $1 from $2 at Stifel
Best Analysts Covering Affimed
Which Analyst Should I Follow If I Want to Buy DE:A28 and Sell After:
1 Month
3 Months
1 Year
Success Rate
2/7 ratings generated profit
Average Return
-14.69%
reiterated a buy rating 5 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -14.69% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
A28 Analyst Recommendation Trends
Rating
Jun 23
Aug 23
Oct 23
Nov 23
Dec 23
Strong Buy
0
0
0
0
0
Buy
8
10
7
10
7
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
10
7
10
7
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
A28 Financial Forecast
A28 Stock Forecast FAQ
What is DE:A28’s average 12-month price target, according to analysts?
Based on analyst ratings, Affimed’s 12-month average price target is €4.57.
What is DE:A28’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:A28, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Affimed a Buy, Sell or Hold?
Affimed has a conensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Affimed’s share price target?
The average share price target for Affimed is €4.57. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €4.57 ,and the lowest forecast is €4.57. The average share price target represents -1.98% Decrease from the current price of €4.659.
The highest analyst share price target is €4.57 ,and the lowest forecast is €4.57. The average share price target represents -1.98% Decrease from the current price of €4.659.
What do analysts say about Affimed?
Affimed’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Affimed?
To buy shares of DE:A28, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.